APA

Kerwin E. M., Taveras H., Iverson H., Wayne D., Shah T., Lepore M. S. & Miller D. S. (20160811). Pharmacokinetics, Pharmacodynamics, Efficacy, and Safety of Albuterol (Salbuterol) Multi-dose Dry-Powder Inhaler and ProAir(®) Hydrofluoroalkane for the Treatment of Persistent Asthma: Results of Two Randomized Double-Blind Studies. : Clinical drug investigation.

Chicago

Kerwin Edward M, Taveras Herminia, Iverson Harald, Wayne Denise, Shah Tushar, Lepore Mark S and Miller David S. 20160811. Pharmacokinetics, Pharmacodynamics, Efficacy, and Safety of Albuterol (Salbuterol) Multi-dose Dry-Powder Inhaler and ProAir(®) Hydrofluoroalkane for the Treatment of Persistent Asthma: Results of Two Randomized Double-Blind Studies. : Clinical drug investigation.

Harvard

Kerwin E. M., Taveras H., Iverson H., Wayne D., Shah T., Lepore M. S. and Miller D. S. (20160811). Pharmacokinetics, Pharmacodynamics, Efficacy, and Safety of Albuterol (Salbuterol) Multi-dose Dry-Powder Inhaler and ProAir(®) Hydrofluoroalkane for the Treatment of Persistent Asthma: Results of Two Randomized Double-Blind Studies. : Clinical drug investigation.

MLA

Kerwin Edward M, Taveras Herminia, Iverson Harald, Wayne Denise, Shah Tushar, Lepore Mark S and Miller David S. Pharmacokinetics, Pharmacodynamics, Efficacy, and Safety of Albuterol (Salbuterol) Multi-dose Dry-Powder Inhaler and ProAir(®) Hydrofluoroalkane for the Treatment of Persistent Asthma: Results of Two Randomized Double-Blind Studies. : Clinical drug investigation. 20160811.